Search clinical trials for: FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZ

Total 121 results

Guidant Corporation

Suspended

SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes (SALT)

Bradycardia

Sweden
Guidant Corporation

Completed

Austria Study - Analysis of Difference Between Active and Passive Fixation Leads

Heart Block | Bradycardia | Sick Sinus Syndrome

Austria
Stanford University

Terminated

Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

Hypertension | Insulin Resistance | Dyslipidemia

United States
Boehringer Ingelheim

Terminated

SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

Hypertension | Coronary Arteriosclerosis

Germany
Boehringer Ingelheim

Completed

Micardis® in Patients With Essential Hypertension

Hypertension
University of Hawaii
Queens Medical Center

Terminated

INvestigating TELmisartin Study (INTEL)

Covid19

United States
Istanbul Medipol University Hospital

Completed

Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity

Visual Impairment | Motor Delay | Premature Retinopathy

Turkey
Novartis

Completed

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal (ASSERTIVE)

Hypertension

Brazil, Canada, Ecuador, Germany, Hungary, Korea, Republic of, Malaysia, Mexico, Panama, Philippines, Singapore, Slovakia, Spain, Turkey, United Kingdom, Venezuela
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Prof. Arie Levine

Completed

Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Israel, Canada
Takeda

Completed

A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Essential Hypertension Complicated by Type 2 Diabetes Mellitus

Japan
The George Institute

Completed

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)

COVID-19 | Coronavirus Disease 2019

Australia, India
Laboratorio Elea Phoenix S.A.
Carlos R. Rojo, MD; Facultad de Medicina, Universidad de Buenos Aires, UBA

Completed

Telmisartan for Treatment of COVID-19 Patients

COVID-19 Drug Treatment

Argentina
Farma de Colombia SA

Completed

Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

Hypertension

Colombia, Ecuador
Boehringer Ingelheim

Completed

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

Hypertension

United States, Argentina, Canada, Chile, Mexico, Peru
Boehringer Ingelheim

Completed

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

Healthy
Chong Kun Dang Pharmaceutical

Completed

CKD-828 Telmisartan Non-Responder Trial

Hypertension

Korea, Republic of
Boehringer Ingelheim

Completed

Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

Healthy
Laboratorios Sophia S.A de C.V.

Terminated

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. (PRO-157)

Conjunctivitis, Bacterial

Mexico
HanAll BioPharma Co., Ltd.

Completed

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

Hypertension

Korea, Republic of
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

Bladder Cancer

China
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
Aristotle University Of Thessaloniki

Unknown

Comparative Study of the Effects of Telmisartan and Nebivolol (TELNEB)

Hypertension

Greece
Medical University of Vienna
Roche Pharma AG

Completed

Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients (PONTIAC)

Coronary Artery Disease | Heart Failure | Diabetes Mellitus

Austria
Prevencion

Unknown

INTERVENCION Trial (INTERVENCION)

Blood Pressure, High

Peru
Boehringer Ingelheim

Completed

Telmisartan 80mg Non-responder Trial

Hypertension

Japan
Boehringer Ingelheim

Completed

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

Hypertension

Germany, Italy, Mexico, Netherlands, Poland
Boehringer Ingelheim

Completed

Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

Healthy
Chong Kun Dang Pharmaceutical
Asan Medical Center

Completed

CKD-828 Drug Interaction Study (Telmisartan)

Healthy Male Volunteers

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media

Otitis Media
The Children's Hospital of Zhejiang University...
First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Qilu Hospital... and other collaborators

Recruiting

Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis

Cytokine Storm | Hemophagocytic Lymphohistiocytoses

China
Boehringer Ingelheim

Completed

26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

Hypertension

Australia, Austria, Bulgaria, Czech Republic, Ireland, Italy, New Zealand, Russian Federation, Slovakia, Spain, Ukraine, United Kingdom
Faes Farma, S.A.

Completed

A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine

Healthy

United States
Helsinn Healthcare SA

Completed

Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects

Healthy Volunteers | Non-smokers

United States
Addpharma Inc.

Completed

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

Hypertension,Essential

Korea, Republic of
University Hospital, Bordeaux

Completed

Population Pharmacokinetics of Anti-infectious Drugs in Children (PHARMA-A)

Pediatrics | Ceftazidime | Voriconazole | Ciprofloxacin

France
UNICANCER
Pfizer; NanoString Technologies, Inc.

Completed

Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women (NeoPAL)

Neoadjuvant Operable Breast Cancer

France
University of Massachusetts, Worcester
National Institutes of Health (NIH)

Completed

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Yuhan Corporation

Completed

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Hypertension

Korea, Republic of
Boehringer Ingelheim

Completed

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

Hypertension

United States, Argentina, Brazil, Mexico, South Africa
Johannes Gutenberg University Mainz

Unknown

Telmisartan, Amlodipine and Flow Mediated Dilation (TEAMSTAprotect)

Hypertension

Germany
Sutro Biopharma, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaborators

Recruiting

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer

United States, Australia, Korea, Republic of, Israel, Singapore, Canada
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

Breast Cancer

China
SOLTI Breast Cancer Research Group
Novartis

Completed

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. (CORALLEEN)

Breast Cancer

Spain
Hebei Medical University Fourth Hospital

Recruiting

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

Breast Cancer

China
National Cancer Center, Korea

Recruiting

Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer (NeoChAI)

Breast Cancer | Invasive Breast Cancer

Korea, Republic of
Spanish Breast Cancer Research Group
Pfizer

Completed

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

Breast Cancer

Spain
Imperial College London

Completed

Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery

Breast Cancer

United Kingdom, Korea, Republic of
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen University; First People's Hospital of Foshan

Completed

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

Metastatic Breast Cancer

China
Nanfang Hospital of Southern Medical University

Unknown

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease (NF-NAFLD)

Nonalcoholic Fatty Liver Disease (NAFLD)

China

3

Subscribe